Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Chloride voltage-gated channel 6 (CLCN6), also known as ClC-6 or KIAA0046, is encoded by the CLCN6 gene on chromosome 1p36.22. CLCN6 is a multi-pass transmembrane protein belonging to the CLC family of chloride transport proteins. Unlike the plasma-membrane-located CLC chloride channels (ClC-1, ClC-2, ClC-Ka, ClC-Kb), CLCN6 is an intracellular member of this family and serving as a chloride/proton exchanger rather than a classical chloride channel. CLCN6 is primarily localized to the membranes of late endosomes and lysosomes, where CLCN6 mediates the coupled exchange of chloride ions against protons and contributes to the acidification of the late endosomal lumen. The protein is expressed in the nervous system and is also detected in testis, ovary, small intestine, brain, and skeletal muscle. Currently, the Cryo-EM structure of human ClC-6 has been identified, revealing the molecular architecture of the transporter and identifying a previously unrecognized ATP-binding site in its cytosolic domains that enhances ion transport activity.
CLCN6 functions as a voltage-gated chloride/proton antiporterregulating the ionic homeostasis of the endolysosomal system. The exchange activity of CLCN6 depends on pH values and relies on the V-ATPase to maintain the acidic environment of late endosomes and lysosomes. Through this transport function, CLCN6 heips maintain the maintenance of lysosomal enzyme activity and autophagic flux. Pathogenic variants in CLCN6, including the gain-of-function mutations p.Tyr553Cys and p.Thr520Ala, induce larger steady-state currents by selectively transporting chloride independently of the acidic environment. Expression of these variants in cells leads to the formation of giant cytoplasmic vacuoles, reduced endosomal acidity, impaired endocytosis, and defective incorporation of lysosomal enzymes. Mutations in CLCN6 cause childhood-onset neurodegeneration with hypotonia, respiratory insufficiency, and brain imaging abnormalities, and have also been identified as a novel genetic cause of neuronal ceroid lipofuscinosis (NCL). These features make CLCN6 an important research target for studies of endolysosomal ion transport, lysosomal function, autophagy, and the molecular mechanisms underlying CLCN6-associated neurodegenerative disorders.
Fig. 1 Development of a polyclonal antibody against human ClC-6 (hClC-6).1
CLCN6, encoded by the CLCN6 gene, functions as a late endosomal chloride/proton exchanger that regulates the ionic homeostasis and function of the endolysosomal system:
Creative Biolabs offers high-quality CLCN6 membrane protein products produced using optimized expression systems. These include full-length multi-pass transmembrane protein that retains the native transporter architecture and cytosolic domains, as well as isolated domain variants. The multi-transmembrane architecture and cytosolic domains mediate chloride/proton exchange activity and ATP-dependent regulation, making these proteins suitable for studies of endolysosomal ion transport, transporter regulation, and protein structure-function characterization. All CLCN6 proteins undergo strict quality control to support consistent performance across applicable research platforms.
Not finding the protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom-engineered CLCN6 stable cell lines, including overexpression and knockdown models. These cell lines are optimized for studies of late endosomal ion transport, lysosomal function, autophagic flux, and CLCN6-associated neurodegeneration mechanisms. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting CLCN6 are developed using antibody engineering technologies for research applications involving CLCN6 expression and localization. These antibodies can be used in studies of CLCN6 distribution in late endosomal and lysosomal compartments and may also support characterization of CLCN6-containing transport complexes in combination with appropriate detection reagents.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for CLCN6 research:
CLCN6 is a late endosomal chloride/proton exchanger that regulates lysosomal acidification and autophagic flux.
CLCN6 is essential for endolysosomal ion homeostasis and lysosomal function. Its mutations cause childhood-onset neurodegeneration and neuronal ceroid lipofuscinosis, making it important for studies of ion transport, autophagy, and neurodegenerative disease mechanisms.
No, all CLCN6 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.
Offerings include full-length CLCN6 membrane proteins, domain variants, specific detection antibodies, and custom stable cell lines for endolysosomal ion transport and neurodegeneration research.
CLCN6 proteins may support studies of ion transport and ATP-binding, depending on protein format and experimental context.